These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 7527672)

  • 1. Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis.
    Valent P; Spanblöchl E; Bankl HC; Sperr WR; Marosi C; Pirc-Danoewinata H; Virgolini I; Eichler HG; Agis H; Sillaber C
    Blood; 1994 Dec; 84(12):4322-32. PubMed ID: 7527672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
    Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
    Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of tryptase-positive KU812 cells cultured in the presence of Steel factor.
    Saito H; Miura K; Takahashi G; Ebisawa M; Matsumoto K; Shichijo M; Onda T; Iikura Y; Yanagihara Y; Ra C
    Int Arch Allergy Immunol; 1995; 107(1-3):330-2. PubMed ID: 7542083
    [No Abstract]   [Full Text] [Related]  

  • 4. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
    Rottem M; Okada T; Goff JP; Metcalfe DD
    Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
    Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
    Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
    Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
    Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mast cell growth factor on clonogenic blast cell growth in acute myelogenous leukemia.
    Siitonen T; Lundström M; Zheng A; Savolainen ER; Koistinen P
    Ann Hematol; 1996 Aug; 73(2):71-8. PubMed ID: 8774615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.
    Irani AM; Nilsson G; Miettinen U; Craig SS; Ashman LK; Ishizaka T; Zsebo KM; Schwartz LB
    Blood; 1992 Dec; 80(12):3009-21. PubMed ID: 1281684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
    Siitonen T; Savolainen ER; Koistinen P
    Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells.
    Brizzi MF; Blechman JM; Cavalloni G; Givol D; Yarden Y; Pegoraro L
    Oncogene; 1994 Jun; 9(6):1583-9. PubMed ID: 7514283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.
    Horny HP; Valent P
    Leuk Res; 2001 Jul; 25(7):543-51. PubMed ID: 11377679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells.
    Wimazal F; Sperr WR; Horny HP; Carroll V; Binder BR; Fonatsch C; Walchshofer S; Födinger M; Schwarzinger I; Samorapoompichit P; Chott A; Dvorak AM; Lechner K; Valent P
    Am J Hematol; 1999 May; 61(1):66-77. PubMed ID: 10331514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
    Schneeweiss M; Peter B; Bibi S; Eisenwort G; Smiljkovic D; Blatt K; Jawhar M; Berger D; Stefanzl G; Herndlhofer S; Greiner G; Hoermann G; Hadzijusufovic E; Gleixner KV; Bettelheim P; Geissler K; Sperr WR; Reiter A; Arock M; Valent P
    Haematologica; 2018 May; 103(5):799-809. PubMed ID: 29439183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptase a novel biochemical marker of acute myeloid leukemia.
    Sperr WR; Hauswirth AW; Valent P
    Leuk Lymphoma; 2002 Dec; 43(12):2257-61. PubMed ID: 12613510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization.
    Sperr WR; Bankl HC; Mundigler G; Klappacher G; Grossschmidt K; Agis H; Simon P; Laufer P; Imhof M; Radaszkiewicz T; Glogar D; Lechner K; Valent P
    Blood; 1994 Dec; 84(11):3876-84. PubMed ID: 7524750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells.
    Nilsson G; Miettinen U; Ishizaka T; Ashman LK; Irani AM; Schwartz LB
    Blood; 1994 Sep; 84(5):1519-27. PubMed ID: 7520776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.